7.95
-0.1(-1.24%)
Currency In EUR
Address
25 Norman Way
Cambridge,
United Kingdom of Great Britain and Northern Ireland
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
November 23, 2021
| Name | Title | Pay | Year Born |
| Dr. Heikki Lanckriet Ph.D. | Chief Executive Officer, Chief Scientific Officer & Executive Director | 598,850 | 1977 |
| Dr. Amy Walker | Chief Operating Officer & Director | 350,559 | N/A |
| Mr. David Roth | Chief Financial Officer, Company Secretary & Executive Director | 429,961 | 1967 |
| Dr. Manja Hermina Elisabeth Maria Boerman Ph.D. | Executive Chair of the Board | 0 | 1966 |
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
